Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?
- PMID: 21592979
- PMCID: PMC3096788
- DOI: 10.1093/infdis/jir144
Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?
Comment on
-
Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.J Infect Dis. 2011 Jun 1;203(11):1534-41. doi: 10.1093/infdis/jir138. J Infect Dis. 2011. PMID: 21592981 Free PMC article.
References
-
- Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–76. - PubMed
-
- Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–63. - PubMed
-
- Bale JF, Miner L, Petheram SJ. Congenital cytomegalovirus infection. Curr Treat Options Neurol. 2002;4:225–30. - PubMed
-
- Williamson WD, Demmler GJ, Percy AK, Catlin FI. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics. 1992;90:862–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
